HR2592-119

What This Bill Does

The Aviation Medication Transparency Act directs the FAA Administrator to publish within one year and maintain on a public FAA website the list of medications and treatments that may be safely prescribed to an airman for medical certification. The list must be drafted in consultation with the Aeromedical Innovation and Modernization Working Group, certified bargaining representatives of FAA air traffic controllers, the principal organization representing the largest certified collective bargaining representative of airline pilots, and other relevant stakeholders. It must be comprehensive, user-friendly, accessible, provided when airmen first seek a license and medical certification, state average periods when an airman must have limited or no duties to stabilize on an approved medication, include FAA Do Not Issue medications, provide a mechanism for doctors or medical providers to contact FAA with questions, explain what conditions a medication may or may not treat and why a medication is allowed or prohibited, and be updated annually as appropriate.

Who Benefits and How

Airline pilots benefit from a public medication list that explains approved treatments, Do Not Issue drugs, and stabilization periods for certification. Air traffic controllers benefit because their certified bargaining representatives must be consulted in drafting the list. Aviation medical examiners benefit from a provider contact mechanism and clearer information about allowed or prohibited medications. Airmen seeking first medical certification benefit because the list must be provided when they first seek a license and medical certificate.

Who Bears the Burden and How

FAA medical certification staff must publish, maintain, explain, and annually update the medication and treatment list. Aeromedical Innovation and Modernization Working Group members must participate in developing the list. Pilot and controller bargaining representatives must provide consultation input. Doctors and medical providers must use the FAA contact mechanism when they need medication-list guidance for airmen.

Key Provisions

• Requires FAA to publish a public medication and treatment list for airman medical certification within one year.
• Requires consultation with aeromedical experts, air traffic controller representatives, pilot representatives, and relevant stakeholders.
• Requires the list to include stabilization-duty periods, Do Not Issue medications, provider contact options, and explanations.
• Requires annual updates to the medication and treatment list after publication.